Results 111 to 120 of about 8,547 (234)
Coexistence of Microscopic Polyangiitis, Systemic Lupus Erythematosus, and Transthyretin Amyloidosis in an Elderly Japanese Patient With Splenic Marginal Zone Lymphoma: An Autopsy Case Report. [PDF]
Nagayama Y +4 more
europepmc +1 more source
ABSTRACT In endemic regions, markedly elevated Brucella serologic titers with a dynamic decline after treatment support true infection even in the presence of monoclonal gammopathy. Concurrent infectious and malignant processes should be considered in patients presenting with severe renal failure and overlapping systemic symptoms to avoid diagnostic ...
Maryam Ghaffari Rahbar +3 more
wiley +1 more source
Genetic heterogeneity correlated with phenotypic variability in 6 Chinese families with Alport syndrome. [PDF]
Gao J, Zhou H, Zhang L, Su Z, Liu S.
europepmc +1 more source
Anifrolumab Dose Regimen Selection for a Phase 3 Trial in Lupus Nephritis
In patients with systemic lupus erythematosus (SLE), increased type I interferon signaling is associated with increased disease activity across organs, including in the kidney, which can cause lupus nephritis (LN). Anifrolumab, which abrogates type I interferon signaling, is an approved treatment for moderate to severe SLE.
Joachim Almquist +6 more
wiley +1 more source
Genetic kidney diseases - from discovery to precision care. [PDF]
Simons M, Hoefele J.
europepmc +1 more source
ITGA5/integrin α5β1 promotes PDAC progression by integrating fibronectin‐dependent adhesion, hypoxia‐associated ECM remodelling, pancreatic stellate cell/cancer‐associated fibroblast activation, desmoplasia and tumour‒stroma crosstalk. These processes contribute to impaired drug delivery and therapeutic resistance.
Chenzhe Ma, Yingying Wang, Yumin Li
wiley +1 more source
Water-Clear Cell Parathyroid Adenoma Causing Delayed Diagnosis and Negative Imaging in Primary Hyperparathyroidism. [PDF]
Hernandez Hernandez M +5 more
europepmc +1 more source
Traditional fermented Kimchi “paocai”, commonly consumed in Northeast China, was screened for probiotic resources capable of degrading uric acid in vitro and alleviating hyperuricemia in a mouse model. Abstract Current pharmacological therapies for hyperuricemia (HUA), though effective, pose safety concerns, including allopurinol‐induced severe dermal ...
Aman Khan +8 more
wiley +1 more source
Regional variation of underlying kidney diseases in children undergoing chronic kidney replacement therapy around the globe. [PDF]
Borzych-Dużałka D +23 more
europepmc +1 more source
Flow chart of RCH to improve TGT‐induced nephrotoxicity. ABSTRACT Researches on Tripterygium glycosides tablets (TGT) often overlook renal toxicity from prolonged use. Rubus chingii Hu (RCH) is beneficial to kidney health and has an unclear role in reducing nephrotoxicity.
Cong Zhang +3 more
wiley +1 more source

